News Image

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

Provided By GlobeNewswire

Last update: Mar 8, 2024

Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched control group receiving conventional stroke therapy.

Read more at globenewswire.com

LIFEWARD LTD

NASDAQ:LFWD (10/13/2025, 8:27:27 PM)

After market: 0.764 +0.01 (+1.81%)

0.7504

+0.01 (+1.47%)



Find more stocks in the Stock Screener

Follow ChartMill for more